The Deal
Tuesday, February 9, 
4:05 pm

Transmeta turns a profit, gets sold for $255.6M

Posted on November 17, 2008 at 5:22 PM
Filed under: Acquisitions
Tagged: , ,
[ Share ]  [ E-mail ]  [ Leave a Comment ]
semiconductorchip2006.jpgTransmeta Corp. is being acquired -- in a take-private deal -- by video processing company Novafora Inc. for $255.6 million in cash. Santa Clara, Calif.-based Transmeta, which develops microprocessors, started looking for strategic options in February after it received an unsolicited bid of $190 million from shareholder Riley Investment Management LLC.

At the time, Riley accused the company of breaches of fiduciary duty, gross mismanagement, waste of corporate assets and abuse of control, The Deal's Donna Block reported. The report said Transmeta, which was founded in 1995, failed to compete against Intel Corp. as a chip supplier -- it transformed itself into a supplier of processor intellectual property in 2005.

Monday's deal terms say that Transmeta may not enter into any future licensing transaction prior to the closing of the merger without Novafora's consent. The firm also turned profitable last quarter and entered into a nonexclusive patent license agreement with Advanced Micro Devices Inc.

The deal is expected to close in the first quarter. - Baz Hiralal

See the deal announcement



Join Corporate Dealmaker's LinkedIn forum

Comments
Post a comment


Search


Search For

Corporate Dealmaker Video


Private equity's slow return to retail M&A

Stephens' Jennifer Herber says private equity buyers may start looking at doing some retail deals.
Decade of The Deal


Movers & Shakers


Adele Gulfo
Pfizer Inc.

Juergen Lasowski
Onyx Pharmaceuticals Inc.

Edward Swallow
Northrop Grumman Corp.

Owen Mahoney
Outspark

Alice Kim
FLO TV Inc.
Adele Gulfo, Pfizer Inc.
Juergen Lasowski, Onyx Pharmaceuticals Inc.
Edward Swallow, Northrop Grumman Corp.
Owen Mahoney, Outspark
Alice Kim, FLO TV Inc.


COMPLETE MOVERS & SHAKERS ARCHIVES

The Magazine


MACDdec1cover.gifAnd the winners are...
Even in a period when things like toxic credit default swaps and noxious structured investment vehicles dominate the conversation in many parts of the deal community, people are still willing to take the time to recognize skill and achievement in the strategic transactions that help those companies adapt and grow.
View the complete issue


Last Issue
Archives
Suggest a topic
Purchase a reprint
Subscribe to The Deal


Monthly Archives


Syndicate

Contributors

footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.